Efficacy of azvudine plus dexamethasone in severe hospitalized patients with Omicron infection: a prospective multicenter study
This study is the first to indicate that treatment with AZV+DXM might benefit severe Omicron-infected patients compared with DXM treatment alone. This finding demonstrates, at least partly, the necessity of antiviral treatment in severe patients.
Authors
- Menglan Zhang (ORCID: https://orcid.org/0000-0002-0997-267X)
- Jinlong Jiang (ORCID: https://orcid.org/0000-0002-2256-1218)
- Xiaoying Wei
- Nan Su (ORCID: https://orcid.org/0000-0002-4564-1595)
- Guifang Xu (ORCID: https://orcid.org/0000-0001-9949-3658)
- Daxiong Zeng (ORCID: https://orcid.org/0000-0002-6476-2974)
Institutions
- Soochow University (CN)
- Suzhou Municipal Hospital (CN)
- First Affiliated Hospital of Soochow University (CN)
- The Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Frontiers in Cellular and Infection Microbiology
- Published
- 2024-11-22
- DOI
- https://doi.org/10.3389/fcimb.2024.1390098
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00